Virtus LifeSci Biotech Clinical Trials ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Virtus LifeSci Biotech Clinical Trls ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 15.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Kodiak Sciences Inc

2.09 850,828
Healthcare

First Tracks Biotherapeutics Inc

2.01 816,341
Healthcare

AbCellera Biologics Inc Ordinary Shares

1.91 776,985
Healthcare

Xencor Inc

1.90 771,853
Healthcare

Amylyx Pharmaceuticals Inc

1.51 615,525
Healthcare

SpyGlass Pharma Inc

1.31 531,758
Healthcare

Nurix Therapeutics Inc Ordinary Shares

1.23 499,877
Healthcare

Prime Medicine Inc

1.22 497,444
Healthcare

SELLAS Life Sciences Group Inc

1.21 493,226
Healthcare

Definium Therapeutics Inc Ordinary Shares

1.17 475,440
Healthcare

Sponsor Center